T-CELL ACTIVATION BY AUTOANTIGENS IN MULTIPLE-SCLEROSIS

被引:6
|
作者
MATSIOTABERNARD, P
ROULLET, E
RAGIMBEAU, J
AVRAMEAS, S
机构
[1] URA 359du CNRS, Unite d'Immunocytochimie, Institut Pasteur, 75724, Paris, Cedex, 15, 25, ruedu Docteur Roux
[2] Service de Neurologie, Hôpital Saint-Antoine, Paris
关键词
MULTIPLE SCLEROSIS; T CELL ACTIVATION MARKERS; AUTOANTIGENS;
D O I
10.3109/08916939309014641
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A panel of autoantigens (myosin, actin, myelin basic protein MBP, and thyroglobulin) was used to analyze antigen recognition by the peripheral blood leukocytes (PBL) of patients with active and stable multiple sclerosis (MS), patients with other neurological diseases (OND) and healthy individuals. The immune responsiveness was studied by examining the in vitro cell proliferation and the increase in the expression of two T-cell-surface activation markers (the interleukin-2 receptor IL-2R, and a late activation antigen recognized by the 19.2 monoclonal antibody). In MS, autoantigen recognition occured more frequently than in the other groups and it was manifested by moderate proliferation or marked elevation of the expression of the IL-2R, whereas autoantigen recognition in the other groups concerned essentially the expression of the late activation antigen. Results similar to those described above were obtained with enriched T lymphocytes either in the presence or absence of IL-2. Our results suggest that the peripheral immune system in MS patients may recognize and can be activated by different autoantigens and not only by MBP, and that this response is quantitatively and qualitatively different from that of PBL from OND patients and healthy individuals.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 50 条
  • [1] T-CELL VACCINATION IN MULTIPLE-SCLEROSIS - HOPES AND FACTS
    ZHANG, JW
    RAUS, J
    ACTA NEUROLOGICA BELGICA, 1994, 94 (02) : 112 - 115
  • [2] T-CELL SUBSETS IN MULTIPLE-SCLEROSIS - A SERIAL STUDY
    CALOPA, M
    BAS, J
    MESTRE, M
    ARBIZU, T
    PERES, J
    BUENDIA, E
    ACTA NEUROLOGICA SCANDINAVICA, 1995, 92 (05): : 361 - 368
  • [3] ADHERENCE-MEDIATED T-CELL ACTIVATION IN MULTIPLE-SCLEROSIS AND OTHER NEUROLOGICAL DISORDERS
    KAMINLEWIS, RM
    KARASANYI, N
    KOSKI, CL
    LEWIS, GK
    JOURNAL OF NEUROIMMUNOLOGY, 1994, 53 (02) : 163 - 171
  • [4] MULTIPLE-SCLEROSIS - A PIVOTAL ROLE FOR THE T-CELL IN LESION DEVELOPMENT
    RAINE, CS
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1991, 17 (04) : 265 - 274
  • [5] T-CELL RECEPTOR ALPHA-CHAIN POLYMORPHISMS IN MULTIPLE-SCLEROSIS
    HASHIMOTO, LL
    MAK, TW
    EBERS, GC
    JOURNAL OF NEUROIMMUNOLOGY, 1992, 40 (01) : 41 - 48
  • [6] INTERFERON-BETA DECREASES T-CELL ACTIVATION AND INTERFERON-GAMMA PRODUCTION IN MULTIPLE-SCLEROSIS
    NORONHA, A
    TOSCAS, A
    JENSEN, MA
    JOURNAL OF NEUROIMMUNOLOGY, 1993, 46 (1-2) : 145 - 154
  • [7] A LONGITUDINAL-STUDY OF THE T-CELL ACTIVATION MARKER CD26 IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS
    CONSTANTINESCU, CS
    KAMOUN, M
    DOTTI, M
    FARBER, RE
    GALETTA, SL
    ROSTAMI, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 130 (02) : 178 - 182
  • [8] HLA AND T-CELL RECEPTOR POLYMORPHISMS IN BELGIAN MULTIPLE-SCLEROSIS PATIENTS - NO EVIDENCE FOR DISEASE ASSOCIATION WITH THE T-CELL RECEPTOR
    VANDEVYVER, C
    BUYSE, I
    PHILIPPAERTS, L
    GHABANBASANI, Z
    MEDAER, R
    CARTON, H
    CASSIMAN, JJ
    RAUS, J
    JOURNAL OF NEUROIMMUNOLOGY, 1994, 52 (01) : 25 - 32
  • [9] THE ROLE OF T-CELLS IN MULTIPLE-SCLEROSIS - IMPLICATIONS FOR THERAPIES TARGETING THE T-CELL RECEPTOR
    UTZ, U
    MCFARLAND, HF
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1994, 53 (04) : 351 - 358
  • [10] NO LINKAGE BETWEEN MULTIPLE-SCLEROSIS AND THE T-CELL RECEPTOR-ALPHA CHAIN LOCUS
    EOLI, M
    WOOD, NW
    KELLARWOOD, HF
    HOLMANS, P
    CLAYTON, D
    COMPSTON, DAS
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 124 (01) : 32 - 37